ASCO Gastrointestinal Cancers Symposium

Frontline Keytruda, Lenvima Betters Duration of Response in Advanced Liver Cancer

January 21st 2024, 2:00pm

Article

Keytrida plus Lenvima improved survival and duration of response in patients with advanced hepatocellular carcinoma.

Avastin Plus Chemo for Metastatic Colorectal Cancer Increases Over Time

January 20th 2024, 8:00pm

Article

The use of the chemotherapy regimen FOLFOXIRI plus Avastin has increased from 2013 to 2022 in patients with metastatic colorectal cancer, particularly in patients aged 50 years and younger.

Patient Characteristics Associated With Longer Remission in CRC

January 20th 2024, 6:00pm

Article

Certain patients with metastatic colorectal cancer were more likely to have long-term remission to Stivarga treatment, recent research showed.

Opdivo-Chemo Combination Improves Survival in GI Cancers

January 19th 2024, 8:00pm

Article

Treatment with Opdivo and chemotherapy improved survival in patients with gastrointestinal cancers, compared with chemotherapy alone, according to a phase 3 trial.

Adding Opdivo to Frontline Chemo Boosts Survival in Advanced GI Cancers

January 18th 2024, 8:00pm

Article

Patients with advanced gastric cancers tended to have better survival outcomes when given Opdivo plus chemotherapy, compared to those who were given chemotherapy alone.

Adding Avastin to Lonsurf Improved Outcomes in Pretreated Colorectal Cancer

January 25th 2023, 2:00pm

Article

Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

SBRT Reduces Side Effects, Treatment Visits in Pancreatic Cancer

January 24th 2023, 10:00pm

Video

Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

Better Quality of Life Reported with Minimally Invasive Esophageal Cancer Treatment

January 23rd 2023, 10:00pm

Article

Patients who underwent minimally invasive treatment tended to have better quality-of-life outcomes than those who had a full esophagus removal, though there were risk factors for long-term outcomes that should be considered.

Lenvima May Prolong Survival in Advanced Liver Cancer That Progressed on Immunotherapy

January 23rd 2023, 2:00pm

Article

Patients with advanced HCC who progressed after treatment with immunotherapy may have a survival benefit when treated with second-line Lenvima.

Quitting Smoking and Drinking May Decrease Depression Risk After Gastric Cancer Surgery

January 22nd 2023, 6:00pm

Article

Patients with gastric cancer who quit smoking and/or drinking after undergoing a gastrectomy tended to have a decreased risk of depression, research showed.